258 related articles for article (PubMed ID: 20565375)
41. Low-dose steroids associated with milder histological changes after pediatric liver transplantation.
Kosola S; Lampela H; Jalanko H; Mäkisalo H; Lohi J; Arola J; Pakarinen MP
Liver Transpl; 2013 Feb; 19(2):145-54. PubMed ID: 23109058
[TBL] [Abstract][Full Text] [Related]
42. Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.
van den Hoogen MW; Hoitsma AJ; Hilbrands LB
Expert Opin Biol Ther; 2012 Aug; 12(8):1031-42. PubMed ID: 22583145
[TBL] [Abstract][Full Text] [Related]
43. Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation.
Schmitt TM; Phillips M; Sawyer RG; Northup P; Hagspiel KD; Pruett TL; Bonatti HJ
Dig Dis Sci; 2010 Nov; 55(11):3224-34. PubMed ID: 20238251
[TBL] [Abstract][Full Text] [Related]
44. Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes.
Ashokkumar C; Sun Q; Ningappa M; Higgs BW; Mazariegos G; Zeevi A; Sindhi R
Transplantation; 2015 Jan; 99(1):164-70. PubMed ID: 25531894
[TBL] [Abstract][Full Text] [Related]
45. Conversion to tacrolimus after liver transplantation.
Jonas S; Bechstein WO; Lemmens HP; Kling N; Grauhan O; Lobeck H; Neuhaus P
Transpl Int; 1996; 9(1):23-31. PubMed ID: 8748407
[TBL] [Abstract][Full Text] [Related]
46. Bortezomib is effective to treat acute humoral rejection after liver transplantation.
Lee CF; Eldeen FZ; Chan KM; Wu TH; Soong RS; Wu TJ; Chou HS; Lee WC
Transplant Proc; 2012 Mar; 44(2):529-31. PubMed ID: 22410063
[TBL] [Abstract][Full Text] [Related]
47. Diagnosis and treatment of steroid resistant cellular rejection in heart transplant recipients--single center experience.
Zakliczyński M; Nozyński J; Zakliczyńska H; Kozłowska K; Trzcińska I; Szewczyk M; Konecka-Mrówka D; Foremny J; Swierad M; Przybylski R; Pisarska H; Wojarski J; Durmała J; Zembala M
Ann Transplant; 2003; 8(1):25-36. PubMed ID: 12848380
[TBL] [Abstract][Full Text] [Related]
48. Thymoglobulin-Resistant T-Cell-Mediated Acute Rejection in a Pregnant Renal Transplant Recipient: Case Report and Review of the Literature.
Balaha M; Al-Otaibi T; Gheith OA; Halim MA; Shaker M; Fayyad Z; Nair P; Zakaria Z; Abo-Atya H; Makkeyia Y
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):159-163. PubMed ID: 30777545
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for steroid-resistant T-cell-mediated acute cellular rejection and their effect on kidney graft and patient outcome.
Awadain W; Gheith O; Hassan A; Hassan N; El-Deeb S; el-Agroudy A; Fouda A; Ghoneim MA
Exp Clin Transplant; 2012 Oct; 10(5):446-53. PubMed ID: 23031083
[TBL] [Abstract][Full Text] [Related]
50. Reduction in corticosteroids is associated with better health-related quality of life after liver transplantation.
Zaydfudim V; Feurer ID; Landman MP; Moore DE; Wright JK; Pinson CW
J Am Coll Surg; 2012 Feb; 214(2):164-73. PubMed ID: 22137824
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of 15-deoxyspergualin on steroid-resistant acute rejection in living related liver transplantation.
Katoh H; Ohkohchi N; Orii T; Doi H; Satomi S
Transplant Proc; 1997; 29(1-2):553-4. PubMed ID: 9123125
[No Abstract] [Full Text] [Related]
52. Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: Results from the ChilSFree study.
Goldschmidt I; Chichelnitskiy E; Götz J; Rübsamen N; Karch A; Jäger V; Kelly D; Lloyd C; Debray D; Girard M; d'Antiga L; di Giorgio A; Hierro L; Pawlowska J; Klaudel-Dreszler M; McLin V; Korff S; Falk C; Baumann U
Liver Transpl; 2024 Mar; 30(3):288-301. PubMed ID: 37678230
[TBL] [Abstract][Full Text] [Related]
53. OKT3 rescue for steroid-resistant rejection in adult liver transplantation.
Solomon H; Gonwa TA; Mor E; Holman MJ; Gibbs J; Watemberg I; Netto G; Goldstein RM; Husberg BS; Klintmalm GB
Transplantation; 1993 Jan; 55(1):87-91. PubMed ID: 8420070
[TBL] [Abstract][Full Text] [Related]
54. Steroid-Resistant Rejection in Liver Transplant: A Single-Center Study for Risk Factor and Second-Line Treatment.
Lee TY; Choi HJ; Seo CH; Ahn J; Hong TH; You YK
Transplant Proc; 2022 Mar; 54(2):443-449. PubMed ID: 35101321
[TBL] [Abstract][Full Text] [Related]
55. Muromonab-CD3 therapy for refractory rejections after liver transplantation: a single-center experience during two decades in Japan.
Ueda D; Hori T; Nguyen JH; Uemoto S
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):885-91. PubMed ID: 20458505
[TBL] [Abstract][Full Text] [Related]
56. Local allograft irradiation as an adjunct for treating severe resistant rejection after liver transplantation in adults.
Ramanathan R; Sharma A; Kaspar M; Behnke M; Song S; Stravitz RT; Cotterell A; Posner M; Fisher RA
Liver Transpl; 2015 Jan; 21(1):47-56. PubMed ID: 25287272
[TBL] [Abstract][Full Text] [Related]
57. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation.
McGillicuddy JW; Taber DJ; Pilch NA; Kohout RK; Bratton CF; Chavin KD; Baliga PK
Prog Transplant; 2013 Mar; 23(1):33-8. PubMed ID: 23448818
[TBL] [Abstract][Full Text] [Related]
58. Autoimmune hemolytic anemia in pediatric liver or combined liver and small bowel transplant patients: a case series and review of the literature.
Li M; Goldfinger D; Yuan S
Transfusion; 2012 Jan; 52(1):48-54. PubMed ID: 21790626
[TBL] [Abstract][Full Text] [Related]
59. A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection.
Colonna JO; Goldstein LI; Brems JJ; Vargas JH; Brill JE; Berquist WJ; Hiatt JR; Busuttil RW
Arch Surg; 1987 Oct; 122(10):1120-3. PubMed ID: 3310962
[TBL] [Abstract][Full Text] [Related]
60. Serum levels of interleukin-9 during acute rejection in liver transplantation.
Fábrega E; López-Hoyos M; San Segundo D; Casafont F; Angel Mieses M; Sampedro B; Pons-Romero F
Transplant Proc; 2012; 44(6):1533-5. PubMed ID: 22841205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
